By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
IndebtaIndebta
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
IndebtaIndebta
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
Indebta > Investing > DraftKings Stock and 2 Other October Plays From J.P. Morgan
Investing

DraftKings Stock and 2 Other October Plays From J.P. Morgan

News Room
Last updated: 2023/10/02 at 5:22 PM
By News Room
Share
3 Min Read
SHARE

The stock market is entering October a little battered and bruised after September’s selloff. However, that also offers opportunities and
J.P. Morgan’s
analysts have some ideas for where to invest at the start of the fourth quarter. 

The bank has updated its Focus List, a compilation of its analysts’ top ideas. Three stocks have been added:
DraftKings
(ticker: DKNG),
Wynn Resorts
(WYNN) and
Boston Scientific
(BSX).

Sports-betting company
DraftKings
has been added as a growth idea, based on improved fundamentals. J.P. Morgan analyst Joseph Greff recently upgraded his rating on the stock to Overweight with a 2024 year-end target price of $37. DraftKings traded up 0.9% at $29.70 in premarket trading on Monday.

Greff is also backing
Wynn Resorts.
He likes the Macau-focused gambling operator as a value play having given it an Overweight rating and a target price of $142 earlier this year. Wynn traded at $92.41 in premarket trading.

The Macau recovery is still intact despite extreme negative sentiment around China knocking Wynn’s shares recently, wrote Greff. Wynn was a Barron’s stock pick earlier this year, based on the Macau rebound opportunity. 

Medical-technology company
Boston Scientific
is a pick from J.P. Morgan’s Robbie Marcus. Recent positive data from a study of pulsed field ablation in patients with atrial fibrillation, or abnormal heartbeats, should underpin confidence in a multiyear growth cycle based on its device pipeline, according to Marcus. 

the analyst has an Overweight rating and $60 target price on Boston Scientific. The shares last traded at $52.50.

It’s also worth noting which stocks have been moved off the Focus List. Boyd Gaming (BYD) and
Las Vegas Sands
(LVS) have been taken out, losing out to DraftKings and Wynn respectively as the preferred growth and value picks in the gambling sector. 

Meanwhile,
Qualcomm
(QCOM) has been taken off as it faces some near-term headwinds related to China’s Huawei, according to J.P. Morgan analyst Samik Chatterjee. Huawei is currently a big purchaser of Qualcomm’s smartphone processors but TF International Securities analyst Ming-Chi Kuo has warned it could lose out on 50 million to 60 million units in orders from 2024 as Huawei adopts self-developed processors.

J.P. Morgan maintained its Overweight ratings on all of Boyd Gaming, Las Vegas Sands, and Qualcomm.

Write to Adam Clark at [email protected]

Read the full article here

News Room October 2, 2023 October 2, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Netflix stock falls after Q3 earnings miss, Tesla preview, OpenAI announces new web browser

Watch full video on YouTube

Why Americans are obsessed with denim

Watch full video on YouTube

Why bomb Sokoto? Trump’s strikes baffle Nigerians

It was around 10pm on Christmas Day when residents of the mainly…

Pressure grows on Target as activist investor builds stake

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

Mosque bombing in Alawite district in Syria leaves at least 8 dead

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

- Advertisement -
Ad imageAd image

You Might Also Like

Investing

Nursing Home Stocks Could Suffer from this Medicaid Spending Remedy

By News Room
Investing

Bitcoin Drops Below $90,000 Again. What Could Move It Next.

By News Room
Investing

These Stocks Are Moving the Most Today: Marvell, Nvidia, Broadcom, GM, Tesla, MongoDB, Burlington, and More

By News Room
Investing

Nvidia Stock Falls as Marvell Earnings Compound AI Gloom. The Rising Risks for Chips.

By News Room
Investing

This analyst says Tesla deliveries will be 16% below expectations. Musk is part of the problem.

By News Room
Investing

BP CEO was awarded no bonus pay from oil giant’s financial performance

By News Room
Investing

Shares of Starlink’s European competitor have tripled. CEO says it can do the job in Ukraine.

By News Room
Investing

GE Vernova Stock Rises as Analyst Flips to Upgrade After Rating Cut

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?